TABLE 2.
Selected Posttransplant Outcomes Excluding Those With Less Than 1 Day of Follow-up (n = 1016)
| NASH Group (n = 205) | Non-NASH Group (n = 811) | P Value | |
|---|---|---|---|
| Days of follow-up | 1285 (759–1924) | 1234 (728–1938) | 0.58 |
| Any rejection | 34 (16.7) | 143 (18.0) | 0.76 |
| Any biliary stricture | 41 (20.1) | 171 (21.4) | 0.76 |
| Hepatic artery thrombosis within 1 year | 6 (3.0) | 28 (3.5) | 0.87 |
| Portal vein thrombosis | 6 (3.0) | 22 (2.7) | 1.00 |
| Atrial fibrillation within 1 year | 28 (13.7) | 111 (13.8) | 1.00 |
| MI within 12 months | 5 (2.5) | 23 (2.9) | 0.94 |
| Stroke within 12 months | 16 (7.8) | 40 (5.0) | 0.16 |
| Heart failure within 12 months | 14 (6.9) | 50 (6.2) | 0.86 |
| Delirium with neurology consult | 29 (14.2) | 98 (12.2) | 0.52 |
| Seizures | 8 (3.9) | 35 (4.4) | 0.93 |
| Viral infection within 12 months | 32 (16.0) | 130 (16.4) | 0.99 |
| Bacterial infection within 12 months | 81 (39.9) | 291 (36.6) | 0.43 |
| Fungal infection within 12 months | 12 (6.0) | 46 (5.8) | 1.00 |
| Days from transplant to extubation | 1 (0–2) | 1 (0–1) | 0.01 |
| Days in ICU after LT | 3 (2–5) | 3 (2–5) | 0.05 |
| Length of stay after LT | 10 (7–17) | 9 (6–15) | 0.01 |
| Post-LT discharge to rehabilitation center | 49 (30.1) | 165 (24.4) | 0.16 |
| Hospital admissions within 12 months | 1 (0–3) | 1 (0–3) | 0.13 |
| Outpatient clinic visits within 12 months | 9 (6–12) | 9 (6–12) | 0.65 |
| >2 returns to the operating room within 12 months | 12 (7.1) | 38 (5.5) | 0.54 |
| Dialysis | |||
| At 1 month | 18 (9.0) | 67 (8.5) | 0.93 |
| At 3 months | 9 (4.6) | 32 (4.2) | 0.96 |
| At 6 months | 5 (2.6) | 24 (3.2) | 0.86 |
| At 12 months | 3 (1.6) | 12 (1.7) | 1.00 |
| Renal failure | |||
| At 1 month* | 35 (17.4) | 100 (12.8) | 0.11 |
| At 3 months | 31 (16.8) | 84 (11.6) | 0.08 |
| At 6 months | 31 (16.8) | 93 (13.2) | 0.25 |
| At 12 months | 31 (17.6) | 92 (13.5) | 0.20 |
| Skin cancer within 12 months | 5 (2.5) | 34 (4.3) | 0.32 |
| PTLD within 12 months | 1 (0.5) | 12 (1.5) | 0.43 |
| Solid organ cancer within 12 months | 7 (3.5) | 43 (5.5) | 0.33 |
| Recurrent HCC | 2 (1.0) | 18 (2.2) | 0.39 |
| Survival outcomes | |||
| Death | 44 (21.5) | 185 (22.8) | 0.75 |
| Retransplant | 2 (1.0) | 15 (1.8) | 0.57 |
| Alive at the end of follow-up | 161 (78.5) | 626 (77.2) | 0.75 |
NOTE: Data are given as median (IQR) or n (%).
*
Renal failure defined as dialysis or eGFR <30 mL/minute/1.73 m2.